Denosumab for the treatment of cancer therapy-induced bone loss and prevention of skeletal-related events in patients with solid tumors.

Denosumab for the treatment of cancer therapy-induced bone loss and prevention of skeletal-related events in patients with solid tumors.

Item
http://www.wikidata.org/entity/Q38040123
The systemic delivery of an oncolytic adenovirus expressing decorin inhibits bone metastasis in a mouse model of human prostate cancer.Bone microenvironment-targeted manipulations for the treatment of osteoblastic metastasis in castration-resistant prostate cancer.Osteoprotegerin expression during the micro- and macrometastatic phases of the osteoblastic metastasis in prostate cancer: therapeutic implications.Skeletal manifestations of treatment of breast cancer on premenopausal women.RANK pathway in giant cell tumor of bone: pathogenesis and therapeutic aspects.Andrographolide prevents human breast cancer-induced osteoclastic bone loss via attenuated RANKL signaling.Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the United States.A multicenter case registry study on medication-related osteonecrosis of the jaw in patients with advanced cancer.Patient preferences for treatments to delay bone metastases.
P2860

Denosumab for the treatment of cancer therapy-induced bone loss and prevention of skeletal-related events in patients with solid tumors.

Item
http://www.wikidata.org/entity/Q38040123
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Denosumab for the treatment of ...... in patients with solid tumors.
@en
type
label
Denosumab for the treatment of ...... in patients with solid tumors.
@en
prefLabel
Denosumab for the treatment of ...... in patients with solid tumors.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Denosumab for the treatment of ...... in patients with solid tumors.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698